MannKind Corporation (MNKD)
MannKind Corporation Market Cap: 306.47M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MNKD Market Cap Rankings
| Overall | 41st percentile | 2714 of 4664 |
| Sector | 55th percentile | 235 of 527 in Healthcare |
| Industry | 65th percentile | 57 of 164 in Biotechnology |
MNKD Market Cap Range, Past 5 Years
| Minimum | 304.29M | Jun 2008 |
| Maximum | 1.094B | Sep 2009 |
| Average | 627.85M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these MNKD related companies
MNKD News
3 Stocks Sink to 52-Week Lows http://stks.co/3lto My story via @TheStreet $DGIT $MNKD $WIN #52WeekLow
about 21 days ago by azendrian
about 21 days ago by azendrian
MannKind Corporation to Hold 2012 First Quarter Financial Results Conference Call on May 9, 2012
May 02, 5:00PM Business Wire
May 02, 5:00PM Business Wire
Tolero and $MNKD Sign Collaboration and License Agreement to Develop and Commercialize Novel BTK Inhibitors. http://stks.co/3ZpY
about 31 days ago by abubnic
about 31 days ago by abubnic
$MNKD great company with great potential for the long run.........few yrs away.
about 42 days ago by BuyWallSt
about 42 days ago by BuyWallSt
@KeySpeculator $MNKD just issued $50m in common stock 2 months ago. I'm just hoping this stock even hits $3 by the end of the year.
about 46 days ago by megreedy
about 46 days ago by megreedy
Though I'm long $MNKD, I read one of the items being voted on was to possibly issue more shares. I just don't see a near term catalyst.
about 47 days ago by megreedy
about 47 days ago by megreedy
$MNKD http://stks.co/3LjS Chart ready to launch; high short interest; one small step for MNKD is one large step for the wallet
about 47 days ago by KeySpeculator
about 47 days ago by KeySpeculator
$MNKD forms bearish "Downside Breakout" chart pattern. http://stks.co/3JQ8
about 49 days ago by RecogniaEvents
about 49 days ago by RecogniaEvents
$MNKD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FWA
about 55 days ago by MarketBrief
about 55 days ago by MarketBrief
Biotech Stocks on the Upswing as Favorable Legislation Boosts Investor Optimism
Mar 19, 8:20AM Marketwire
Mar 19, 8:20AM Marketwire
MannKind to Present at Cowen and Company 32nd Annual Health Care Conference
Feb 29, 5:00PM Business Wire
Feb 29, 5:00PM Business Wire
MannKind Corporation Reports 2011 Fourth Quarter and Full Year Financial Results
Feb 22, 4:00PM Business Wire
Feb 22, 4:00PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MNKD | 1.83 | -0.01 | -0.54% | 306.47M |
| MNI | 2.19 | -0.02 | -0.91% | 187.05M |
| MNE | 15.25 | +0.14 | +0.89% | |
| MNDO | 1.70 | -0.01 | -0.58% | 31.84M |
| MKTX | 32.33 | -0.11 | -0.34% | 1.164B |
| MKTG | 10.34 | -0.01 | -0.10% | 490.53M |
| MKTAY | 33.29 | -0.83 | -2.43% | 4.549B |
| MKSI | 26.17 | -0.26 | -0.98% | 1.375B |
| MKL | 434.25 | -1.00 | -0.23% | 4.191B |
| MKC | 56.57 | -0.77 | -1.34% | 7.501B |
